1. TGFB2 and BCL2L11 methylation in male laryngeal cancer patients.
   Zhisen Shen et al, 2016, Oncol Lett CrossRef
2. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma
   Zhisen Shen et al, 2016, Gene CrossRef
3. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients
   Zhisen Shen et al, 2016, Clinical Biochemistry CrossRef
4. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis
   Fucheng Cai et al, 2016, PLoS ONE CrossRef
5. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis
   Tianyi Wu et al, 2016, Oncotarget CrossRef
6. Circ_0000218 plays a carcinogenic role in laryngeal cancer through regulating microRNA-139-3p/Smad3 axis
   Yiyang Bai et al, 2020, Pathology - Research and Practice CrossRef
7. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
   Wei Wu et al, 2021, Pharmacol Res CrossRef
8. A Low-Rank Representation Method Regularized by Dual-Hypergraph Laplacian for Selecting Differentially Expressed Genes
   Xiu-Xiu Xu et al, 2019, Hum Hered CrossRef
9. Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma
   Meixuan Wan et al, 2023, Infect Agents Cancer CrossRef
10. Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)
    Yasamin Yousefi et al, 2024, J Neurooncol CrossRef